4Lloyed J,Bochner F.Aspirin:how low is low-dose? Medicine Digest,1997,5:14.
5Brownlee M,Cerami A,Vlassara H.Advanced glycosylation end products in tissue and the biochemic basis of diabetic complications. N Engl J Med,1988,318:1315.
6Makita Z,Vlassara H,Rayfield E et al.Hemoglobin-AGE:a circulating marker for advanced glycosylation, Science 1992,258:651.
7The DAMAD Study Group, Effect of aspirin along and aspirin plus dipyridamole in early diabetic retinopathy,a multicenter randomized controlled clinical trail.Diabetes1989,38:491.
8Mole DI,Safirstein RL,Mcervy RC et al.Effect of aspirin on experimental diabetic nephropathy,J Lab Clin Med,1987,110:300.
9Sensi M,Bruno MR,Pozzilli P. In vitro inhibition of non-enzymatic glycosylation induced by aspirin.Med Sic Res,1987,15:99.
